One of the key figures behind Healthspan Capital is General Partner Sebastian Brunemeier, a biotech venture capitalist and company builder with a focus on longevity and regenerative medicine. Over the past five years, he has co-founded multiple longevity biotech companies, including Cambrian and Samsara Therapeutics, and we sat down with him to find out more about how Healthspan Capital and its vision is set to serve the need for more capital in the field. https://longevity.technology/news/longevity-biotech-is-the-apotheosis-of-medicine/